(Q34774164)

4 August 2017

1 reference

title

Management of acute promyelocytic leukemia. (English)

1 reference

4 August 2017

1 reference

1

Martin S Tallman

1 reference

4 August 2017

Chadi Nabhan

2

1 reference

4 August 2017

1 September 2002

1 reference

4 August 2017

Current Oncology Reports

1 reference

4 August 2017

4

1 reference

4 August 2017

381-389

1 reference

4 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-002-0031-1

4 August 2017

0 references

cites work

All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-002-0031-1

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases

21 January 2018

1 reference

12 December 2020

A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients

1 reference

12 December 2020

Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia.

1 reference

12 December 2020

Acute promyelocytic leukemia. Therapy results and prognostic factors

1 reference

12 December 2020

Prognostic significance of the RT-PCR assay of PML-RARA transcripts in acute promyelocytic leukemia. The Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho)

1 reference

12 December 2020

Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection

1 reference

12 December 2020

Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid

1 reference

12 December 2020

Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gen

1 reference

12 December 2020

Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses.

1 reference

12 December 2020

Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Mult

1 reference

12 December 2020

Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group

1 reference

12 December 2020

Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients

1 reference

12 December 2020

In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins

1 reference

12 December 2020

Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome

1 reference

12 December 2020

Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemia

1 reference

12 December 2020

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

1 reference

12 December 2020

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

1 reference

12 December 2020

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

1 reference

12 December 2020

Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129

1 reference

12 December 2020

Treatment of Acute Promyelocytic Leukemia: A Report of 70 Cases

1 reference

12 December 2020

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

1 reference

12 December 2020

Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA.

1 reference

12 December 2020

Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia. Australian Leukaemia Study Group

1 reference

12 December 2020

Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. The Leukemia Study Group of the Ministry of Health and Welfar

1 reference

12 December 2020

Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195

1 reference

12 December 2020

A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia

1 reference

12 December 2020

Therapy of molecular relapse in acute promyelocytic leukemia

1 reference

12 December 2020

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

12 December 2020

Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia

1 reference

12 December 2020

HLA class I in acute promyelocytic leukemia (APL): possible correlation with clinical outcome

1 reference

12 December 2020

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells

1 reference

12 December 2020

Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo

1 reference

12 December 2020

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results

1 reference

12 December 2020

Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study

1 reference

12 December 2020

Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.

1 reference

12 December 2020

The short form of PML-RARalpha fusion transcript is associated with poor survival

1 reference

12 December 2020

Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.

1 reference

12 December 2020

High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia.

1 reference

12 December 2020

Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia.

1 reference

12 December 2020

Acute promyelocytic leukemia: results of treatment by daunorubicin

1 reference

12 December 2020

Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR

1 reference

12 December 2020

Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide

1 reference

12 December 2020

Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide.

1 reference

12 December 2020

European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Working Party on Acute Leukemia of the European Cooperative Group for Bone Marrow Transplantation (EMBT).

1 reference

12 December 2020

The role of bone marrow transplantation in acute promyelocytic leukemia

1 reference

12 December 2020

Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA.

1 reference

12 December 2020

Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia

1 reference

12 December 2020

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group

1 reference

12 December 2020

Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia

1 reference

12 December 2020

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.

1 reference

12 December 2020

CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?

1 reference

12 December 2020

Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse

1 reference

12 December 2020

[Acute promyelocytic leukemia: retrospective study of 119 patients treated with daunorubicin]

1 reference

12 December 2020

Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncolo

1 reference

12 December 2020

Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage

1 reference

12 December 2020

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

12 December 2020

Role of maintenance chemotherapy in acute promyelocytic leukemia.

1 reference

12 December 2020

Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial

1 reference

12 December 2020

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups

1 reference

12 December 2020

P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia

1 reference

12 December 2020

AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study

1 reference

12 December 2020

Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway

1 reference

12 December 2020

Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group

1 reference

12 December 2020

Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment

1 reference

12 December 2020

CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy

1 reference

12 December 2020

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients

1 reference

12 December 2020

Acute promyelocytic leukemia. Management of the coagulopathy during daunorubicin-prednisone remission induction

1 reference

12 December 2020

Acute promyelocytic leukemia: clinical aspects and results of treatment in 62 patients

1 reference

12 December 2020

All-trans-retinoic acid in acute promyelocytic leukemia

1 reference

12 December 2020

Retinoic acids in the treatment of acute promyelocytic leukemia

1 reference

12 December 2020

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

1 reference

12 December 2020

Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RARalpha transcripts with a sensitive competitive RT-PCR method.

1 reference

12 December 2020

Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.

1 reference

12 December 2020

Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells

1 reference

12 December 2020

10.1007/S11912-002-0031-1

Identifiers

DOI

1 reference

PubMed ID

12162911

Dimensions Publication ID

4 August 2017

1048804389

0 references

Fatcat ID

release_tegvaokgo5dxdijtxobi7dwzua

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tegvaokgo5dxdijtxobi7dwzua

24 November 2022

mapped directly with Wikidata item

PubMed ID

12162911

1 reference

PubMed ID

12162911